Infinimmune Raises $75M for Antibody Discovery
Infinimmune secured $75 million in funding, with Regeneron leading the investment.
A new company, Infinimmune, just got a big boost. It raised $75 million to help find new ways to fight diseases. Regeneron, a major drug maker, led this new funding round. This money will help Infinimmune with its work on antibodies.
Antibodies are like the body's tiny soldiers. They find and fight off bad germs and sickness. Infinimmune uses new technology to discover these important antibodies. This could lead to new medicines for many different health problems.
Regeneron's investment shows they believe in Infinimmune's science. This partnership could speed up the discovery of new treatments. The goal is to bring these life-changing medicines to people sooner.
Source: FierceBiotech
More from Biotech
